文献速递新发突发、热带与寄生虫病

孕期间歇性预防治疗不足与贝宁孕妇亚显微恶性疟原虫感染风险增加相关

Suboptimal Intermittent Preventive Treatment in Pregnancy (IPTp) is Associated With an Increased Risk of Submicroscopic Plasmodium falciparum Infection in Pregnant Women: A Prospective Cohort Study in Benin.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该前瞻性队列研究纳入273名贝宁孕妇,每月用显微镜和PCR筛查恶性疟原虫感染,评估IPTp-SP剂量与时机对感染数的影响。77.3%孕妇至少服用2剂,首次服药中位孕龄22周;

要点

  • 首次IPTp-SP服药晚于21.2周与恶性疟原虫感染数增加边缘相关。
  • IPTp-SP剂量数与亚显微恶性疟原虫感染数无显著关联。
  • 需研发可在孕早期服用的新抗疟药用于IPTp。

核心结论

  • 首次IPTp-SP服药过晚未能提供针对恶性疟原虫的最佳保护,尤其是亚显微感染。

研究设计与样本

  • 前瞻性队列研究,纳入273名贝宁孕妇,全程随访至分娩。

主要发现

  • 77.3%的孕妇至少服用2剂IPTp-SP,首次服药中位孕龄为22周。

临床怎么用

  • 应关注IPTp-SP首次服药时机,避免过晚启动以增强对亚显微感染的保护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Harmful maternal and neonatal health outcomes result from malaria in pregnancy, the prevention of which primarily relies on intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP). The World Health Organization recommends IPTp-SP in sub-Saharan Africa, but implementation is highly heterogeneous and often suboptimal in terms of the number of doses and their timing. In this study, we assessed the impact of this heterogeneity on malaria in pregnancy, mainly with respect to submicroscopic Plasmodium falciparum infections. METHODS: We used data from 273 Beninese women followed throughout pregnancy. Screening for P. falciparum infections, using both microscopy-based and polymerase chain reaction (PCR)-based methods, was performed monthly, and information on IPTp-SP doses was collected. Gestational age was estimated by repeated ultrasound scans. Using a negative binomial model, we investigated the effect of IPTp-SP doses and timing after 17 weeks of gestation on the number of P. falciparum infections, focusing on submicroscopic infections detectable only by PCR. RESULTS: At least 2 IPTp-SP doses were taken by 77.3% of the women. The median gestational age at the first IPTp-SP dose was 22 weeks. A late first IPTp-SP dose (>21.2 weeks) was marginally associated with an increased number of P. falciparum infections (adjusted incidence rate ratio [aIRR] = 1.3; P = .098). The number of IPTp-SP doses was not associated with the number of submicroscopic infections (aIRR = 1.2, P = .543). CONCLUSIONS: A late first IPTp-SP dose failed to provide optimal protection against P. falciparum, especially submicroscopic infections. This highlights the need for a new antimalarial drug for IPTp that could be taken early in pregnancy.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Hounkonnou CPA, Ndam NT, Fievet N, et al. Suboptimal Intermittent Preventive Treatment in Pregnancy (IPTp) is Associated With an Increased Risk of Submicroscopic Plasmodium falciparum Infection in Pregnant Women: A Prospective Cohort Study in Benin. Clin Infect Dis. 2021. PMID: 32901806. doi:10.1093/cid/ciaa1355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。